Drug Type Small molecule drug |
Synonyms- |
Action antagonists, inhibitors, modulators |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists), Proton pump inhibitors, Bone development modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (16 Oct 2000), |
Regulation- |
Molecular FormulaCH2CaO3 |
InChIKeyFYHXNYLLNIKZMR-UHFFFAOYSA-N |
CAS Registry471-34-1 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Heartburn | United States | 16 Oct 2000 |
Phase 1 | 24 | Famotidine (Famotidine/Antacid Combination EZ Chew Tablet Without Water) | sqferdlwbu(lobsdwmhea) = atkskbwnoy xazvrwygrn (kifvgndigu, zmsxodxbqp - rlgnuerrlz) View more | - | 24 Jun 2015 | ||
Famotidine (Famotidine/Antacid Combination Tablet With Water) | sqferdlwbu(lobsdwmhea) = cpaldftpqi xazvrwygrn (kifvgndigu, preyarlfsp - sbjhvfeihb) View more |





